Effects of Chemotherapy on Alpha-Fetoprotein in Liver Cancer Cells
Author Information
Author(s): A. Muraoka, T. Tokiwa, J. Sato
Primary Institution: Cancer Institute, Okayama University Medical School
Hypothesis
The study investigates the effects of various chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
Conclusion
The study concludes that serum alpha-fetoprotein levels in patients with hepatomas correlate with the size of viable tumor mass rather than the total tumor size, and that the AFP-secreting capacity of tumor cells remains unchanged after chemotherapy.
Supporting Evidence
- There was a high correlation between hepatoma cell number and AFP secretion after treatment.
- The amount of AFP secreted per cell per 72h was not affected by therapeutically achievable concentrations of chemotherapeutic agents.
- Chemotherapeutic agents inhibited both cell growth and AFP secretion in a dose-dependent manner.
Takeaway
This study looked at how cancer treatment affects a protein called alpha-fetoprotein in liver cancer cells. It found that the amount of this protein can show how much of the cancer is still alive, even after treatment.
Methodology
The study used human hepatocellular carcinoma and hepatoblastoma cell lines, treated them with various chemotherapeutic agents, and measured cell growth and AFP secretion.
Limitations
The study may not reflect the exact AFP-secreting capacity of cells at higher concentrations of chemotherapeutic agents due to cell toxicity.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website